[Asia Economy] 2011.09.19
[Summarized and Translated by Unhwa]
On September 16th, Unhwa and Chung-Ang University Hospital have signed MOU to begin joint-research on plant stem cell for commercialization in cosmetic and pharmaceutical business.
Through this alliance, Unhwa will work with Chung-Ang University hospital to develop various biomaterials for commercialization. Once potential material for commercialization is discovered, Chung-Ang University Hospital will conduct animal/ human research and develop corresponding care and treatment.
"We believe this cooperation will accelerate our goal of becoming a research-based hospital, since it marks the beginning of constructing human/ technological network with excellent research-focused industries at home and overseas,” said an official at Chung-Ang University Hospital.
As Unhwa has secured the world’s only plant stem cell technology that facilitates mass production of useful plant compounds, Chung-Ang University Hospital is willing to lay groundwork for manufacturing and developing plant stem cell products by means of commercialization effort.
Once this cooperation proves to be successful, Unhwa prospects transfer of technology to other pharmaceutical/ cosmetic businesses.
On one hand, Unhwa is making a significant progress in developing AIDS adjuvant in U.S. using botanical drug.